TXG

10X GENOMICS, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

62.32
-0.48
-0.76%
Closed 16:41 03/31 EDT
OPEN
63.36
PREV CLOSE
62.80
HIGH
63.36
LOW
60.32
VOLUME
286.19K
TURNOVER
--
52 WEEK HIGH
108.36
52 WEEK LOW
45.11
MARKET CAP
6.02B
P/E (TTM)
-189.4801
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TXG stock price target is 94.60 with a high estimate of 113.00 and a low estimate of 75.00.

EPS

TXG News

More
  • 10x Genomics: A Second Chance To Buy Into The Growth Story
  • Seeking Alpha - Article · 2d ago
  • Hedge Funds Were Getting Burned By 10x Genomics, Inc. (TXG) Before The Coronavirus
  • Insider Monkey · 03/23 15:45
  • Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2019 Update
  • Seeking Alpha - Article · 03/08 17:51
  • U.S. IPO Week Ahead: One Biotech Takes On A Turbulent IPO Market
  • Seeking Alpha - Article · 03/07 19:20

Industry

Medical Equipment, Supplies & Distribution
-0.22%
Healthcare Equipment & Supplies
-0.66%

Hot Stocks

Symbol
Price
%Change

About TXG

10x Genomics, Inc. is a life science technology company. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The Company’s product consists of chromium single cell gene expression solution, cell immune profiling solution, cell copy number variation (CNV) solution, Cell assay for transposase accessible chromatin (ATAC) solution. The Company’s Chromium platform enables analysis of individual biological components, such as up to millions of single cells. Its Visium platform is designed to identify where biological components are located and how they are arranged with respect to each other. Its molecular assays are used with its Chromium platform, and with its planned Visium platform, to provide sensitive and robust biochemistries that convert minute amounts of biological analytes into detectable signals.
More

Webull offers kinds of 10X Genomics Inc stock information, including NASDAQ:TXG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TXG stock news, and many more online research tools to help you make informed decisions.